The risk of cardiovascular disease in prostate cancer patients receiving androgen deprivation therapies.

BACKGROUND: Androgen deprivation therapy (ADT), with a proven role in prostate cancer management, has been associated with various cardiovascular diseases. However, few studies have investigated these associations by type of ADT, particularly for newer ADTs such as the gonadotropin-releasing hormone...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Epidemiology
Main Authors: Cardwell, Chris R., O’Sullivan, Joe M., Jain, Suneil, Harbinson, Mark T., Cook, Michael B., Hicks, Blánaid M., Menamin, Úna C. Mc
Format: Artigo
Jezik:Inglês
Izdano: 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7138701/
https://ncbi.nlm.nih.gov/pubmed/31651660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/EDE.0000000000001132
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki